Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Citric Acid → Trisodium citrate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Citric Acid | HCID 311 | — |
| 반응물 | Water | HCID 962 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | Duloxetine | HCID 60835 | — |
| 반응물 | Sodium Bicarbonate | HCID 516892 | — |
| 생성물 | Trisodium citrate | HCID 6224 | — |
| 생성물 | Tripotassium citrate | HCID 13344 | — |
| 생성물 | Duloxetine | HCID 60835 | — |
반응 단계
Effervescent Tablets and Granules were prepared using standards techniques known to persons skilled in the art. For Example: From one 20 mg duloxetine capsule, granules were emptied into mortar and pestle to prepare fine powder. A homogeneous mixture of effervescent duloxetine powder was obtained by diluting the above powdered duloxetine with about 958 mg sodium bicarbonate USP, about 832 mg citric acid USP and about 312 mg potassium carbonate USP. This powder reacted with the 60 ml water to create effervescence resulting in a bubbling solution of duloxetine with sodium citrate and potassium citrate as principal antacids
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08093408B2 |
| 출처 데이터셋 | uspto-grants-2012_01 |
| ORD ID | ord-3fe1b42f4dd541bba16678b948a2ee70 |
| 출처 메모 | uspto-grants-2012_01 |